BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 20471543)

  • 1. Morphine versus midazolam as upfront therapy to control dyspnea perception in cancer patients while its underlying cause is sought or treated.
    Navigante AH; Castro MA; Cerchietti LC
    J Pain Symptom Manage; 2010 May; 39(5):820-30. PubMed ID: 20471543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Midazolam as adjunct therapy to morphine in the alleviation of severe dyspnea perception in patients with advanced cancer.
    Navigante AH; Cerchietti LC; Castro MA; Lutteral MA; Cabalar ME
    J Pain Symptom Manage; 2006 Jan; 31(1):38-47. PubMed ID: 16442481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential opioid-sparing effect of regular benzodiazepines in dyspnea: longer duration of studies needed.
    Currow DC; Abernethy AP
    J Pain Symptom Manage; 2010 Nov; 40(5):e1-2; author reply e2-4. PubMed ID: 20813495
    [No Abstract]   [Full Text] [Related]  

  • 4. Morphine for dyspnea control in terminal cancer patients: is it appropriate in Taiwan?
    Hu WY; Chiu TY; Cheng SY; Chen CY
    J Pain Symptom Manage; 2004 Oct; 28(4):356-63. PubMed ID: 15471653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nebulized versus subcutaneous morphine for patients with cancer dyspnea: a preliminary study.
    Bruera E; Sala R; Spruyt O; Palmer JL; Zhang T; Willey J
    J Pain Symptom Manage; 2005 Jun; 29(6):613-8. PubMed ID: 15963870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "Palliative" and not "terminal" sedation.
    Koh YH; Lee OK; Wu HY
    J Pain Symptom Manage; 2009 Apr; 37(4):e6-8. PubMed ID: 19345295
    [No Abstract]   [Full Text] [Related]  

  • 7. Midazolam as adjunct therapy to morphine to relieve dyspnea?
    Sironi O; Sbanotto A; Banfi MG; Beltrami C
    J Pain Symptom Manage; 2007 Mar; 33(3):233-4; author reply 234-6. PubMed ID: 17349490
    [No Abstract]   [Full Text] [Related]  

  • 8. [Symptomatic treatment of dyspnoea in patients receiving palliative care: nasal delivery of oxygen compared with opioid administration].
    Clemens KE; Klaschik E
    Dtsch Med Wochenschr; 2007 Sep; 132(38):1939-43. PubMed ID: 17853348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Efficacy of controlled-release oxycodone for dyspnea in cancer patients--three case series].
    Shinjo T; Okada M
    Gan To Kagaku Ryoho; 2006 Apr; 33(4):529-32. PubMed ID: 16612168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does nebulized morphine offer symptom relief to patients with disabling dyspnea during end-stage disease?
    Eaton B; Hall J; MacDonald S
    Can Fam Physician; 1999 Feb; 45():319-20. PubMed ID: 10065305
    [No Abstract]   [Full Text] [Related]  

  • 11. [Dyspnea in cancer: causes and symptomatic treatment].
    Sleijfer DT; van der Werf TS; de Mulder PH
    Ned Tijdschr Geneeskd; 1999 Nov; 143(48):2421-4. PubMed ID: 10608976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management.
    Mercadante S; Porzio G; Ferrera P; Fulfaro F; Aielli F; Verna L; Villari P; Ficorella C; Gebbia V; Riina S; Casuccio A; Mangione S
    Eur J Pain; 2008 Nov; 12(8):1040-6. PubMed ID: 18353696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can we really say that nebulized morphine works?
    Lasheen W; Panneerselvam A; Davis MP
    J Pain Symptom Manage; 2006 Aug; 32(2):101-2; author reply 102-3. PubMed ID: 16877173
    [No Abstract]   [Full Text] [Related]  

  • 14. Opioid-induced neurotoxicity.
    Gallagher R
    Can Fam Physician; 2007 Mar; 53(3):426-7. PubMed ID: 17872676
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of ondansetron in lower extremity bone surgery on morphine and tramadol consumption using patient controlled analgesia].
    Cubukçu Z; Ozbek H; Güneş Y; Gündüz M; Ozcengiz D; Işik G
    Agri; 2007 Jan; 19(1):36-41. PubMed ID: 17457705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dexmedetomidine in combination with morphine PCA provides superior analgesia for shockwave lithotripsy.
    Alhashemi JA; Kaki AM
    Can J Anaesth; 2004 Apr; 51(4):342-7. PubMed ID: 15064262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nebulized morphine for relief of dyspnea due to chronic lung disease.
    Brown SJ; Eichner SF; Jones JR
    Ann Pharmacother; 2005 Jun; 39(6):1088-92. PubMed ID: 15840735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Symptomatic therapy of dyspnea with strong opioids and its effect on ventilation in palliative care patients.
    Clemens KE; Klaschik E
    J Pain Symptom Manage; 2007 Apr; 33(4):473-81. PubMed ID: 17397708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dextropropoxyphene versus morphine in opioid-naive cancer patients with pain.
    Mercadante S; Salvaggio L; Dardanoni G; Agnello A; Garofalo S
    J Pain Symptom Manage; 1998 Feb; 15(2):76-81. PubMed ID: 9494305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of sustained release morphine hydrochloride tablets in management of cancer pain: a survey of 567 patients].
    Yu SY; Qiu H; Ma ZS; Chen J; Zhang Y; Chen LZ; Wang DL; Ma ZY
    Zhonghua Yi Xue Za Zhi; 2004 Mar; 84(6):450-5. PubMed ID: 15061959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.